Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Treasury Shares (2021)

Coeptis Therapeutics Holdings (COEP) has 1 years of Treasury Shares data on record, last reported at $247165.0 in Q4 2021.

  • For Q4 2021, Treasury Shares changed N/A year-over-year to $247165.0; the TTM value through Dec 2021 reached $247165.0, changed N/A, while the annual FY2021 figure was $247165.0, N/A changed from the prior year.
  • Treasury Shares reached $247165.0 in Q4 2021 per COEP's latest filing.
  • Across five years, Treasury Shares topped out at $247165.0 in Q4 2021 and bottomed at $247165.0 in Q4 2021.